Cite
HARVARD Citation
Graf, M. et al. (2022). SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD open. 8 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Graf, M. et al. (2022). SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD open. 8 (1), p. . [Online].